Brain delivery systems via mechanism independent of receptor-mediated endocytosis and adsorptive-mediated endocytosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Pharmaceutical Biotechnology

• Publication date

  2012-08-31

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/138920112803341842PMID 23016641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier

  2010cited by this paper
• Macromolecular drug transport into the brain using targeted therapy

  2010cited by this paper
• Structure and function of the blood-brain barrier.

  2010cited by this paper
• Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research.

  2010cited by this paper
• Magnetic nanoparticles and targeted drug delivering.

  2010cited by this paper
• Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.

  2009cited by this paper
• Interaction of nanoparticles with cells.

  2009cited by this paper
• Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.

  2008cited by this paper
• Magnetic nanoparticles for drug delivery applications.

  2008cited by this paper
• ABC transporters and the blood-brain barrier.

  2004cited by this paper
• In Vivo Delivery of Glial Cell-Derived Neurotrophic Factor Across the Blood-Brain Barrier by Gene Transfer into Brain Capillary Endothelial Cells

  2003cited by this paper
• Transluminal Gene Transfer into Brain Capillary Endothelial Cells In Vivo with HVJ-liposomes

  2002cited by this paper
• Drug and gene targeting to the brain with molecular trojan horses

  2002cited by this paper
• Endothelial Vesicles in the Blood–Brain Barrier: Are They Related to Permeability?

  2000cited by this paper
• Selective expression of the large neutral amino acid transporter at the blood-brain barrier.

  1999cited by this paper
• Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.

  1996cited by this paper
• Receptor-mediated endocytosis of transferrin at the blood-brain barrier.

  1993cited by this paper

• Role of microRNAs in glioblastoma

  2021cites this paper
• Drug delivery to the brain

  2019cites this paper
• A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment

  2019cites this paper
• Angiopep-2 modified PEGylated 2-methoxyestradiol micelles to treat the PC12 cells with oxygen-glucose deprivation/reoxygenation.

  2018cites this paper
• Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.

  2018cites this paper
• The Development of a Drug Delivery System Using Brain Endothelial Non-Antibody Binding Domains as Transport Carriers

  2018cites this paper
• Critical Parametric Study on Final Size of Magnetite Nanoparticles

  2018cites this paper
• Novel gold nanoparticles coated with somatostatin as a potential delivery system for targeting somatostatin receptors

  2016cites this paper
• Drug permeation across the blood-brain barrier: applications of nanotechnology.

  2015cites this paper
• Blood Brain Barrier: A Challenge for Effectual Therapy of Brain Tumors

  2015cites this paper
• Diagnostic and therapeutic uses of nanomaterials in the brain.

  2014cites this paper
• Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm

  2014cites this paper
• Is there new hope for therapeutic matrix metalloproteinase inhibition?

  2014cites this paper
• Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution.

  2014cites this paper
• Engineered nanomaterial uptake and tissue distribution: from cell to organism

  2013cites this paper
• Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery

  2013cites this paper